LMAT
HoldFallen FavouriteLeMaitre Vascular, Inc. · Healthcare · United States · $1.8B · Avg Vol: $25M/d
Fallen Favourite: A good business that is expensive and falling. Wait for the price to catch up.
ABOUT LEMAITRE VASCULAR, INC.
Read
LeMaitre Vascular, Inc. is a global provider of medical devices for the treatment of peripheral vascular disease, designing, manufacturing, and marketing a broad portfolio of interventional and implantable devices. LeMaitre Vascular benefits from a comprehensive and specialized product portfolio addressing niche areas of peripheral vascular surgery, supported by a direct sales force. Its focus on innovative solutions for a specific disease state creates a strong competitive advantage.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 161.7M | 193.5M | 219.9M | 249.6M | 15.6% | 262.4M | 276.5M | 302.9M | 10.2% |
| EPS | 0.94 | 1.36 | 1.96 | 2.55 | 39.5% | 2.86 | 2.91 | 3.22 | 12.3% |
| Shares | 22.1M | 22.3M | 22.5M | 22.8M | +3.1% | 22.9M | — | — | — |
| Debt | 16.6M | 19.1M | 185.7M | 185.6M | 123.6% | 190.3M | — | — | — |
| Equity | 268.2M | 297.9M | 337.3M | 393.5M | 13.6% | — | — | — | — |
| Op CF | 25.4M | 36.8M | 44.1M | 81.3M | 47.4% | 83.0M | — | — | — |
| Inv CF | -10.4M | -24.7M | -200.1M | -64.9M | — | — | — | — | — |
| Fin CF | -9.2M | -7.1M | 158.1M | -14.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LMAT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LMAT | LeMaitre Vascular, Inc.(you) | $1.8B | 53 | Hold |
| BLFS | BioLife Solutions, Inc. | $1.8B | 50 | Hold |
| XRAY | DENTSPLY SIRONA Inc. | $2.2B | 58 | Hold |
| AZTA | Azenta, Inc. | $1.4B | 46 | Hold |
| STAA | STAAR Surgical Company | $1.1B | 57 | Hold |
| ATRC | AtriCure, Inc. | $2.5B | 64 | Hold |
| ANGO | AngioDynamics, Inc. | $655M | 52 | Hold |
| ICUI | ICU Medical, Inc. | $4.4B | 63 | Hold |
| WRBY | Warby Parker Inc. | $3.1B | 34 | Sell |
| KMTS | Kestra Medical Technologies, Ltd. | $1.5B | 26 | Sell |
Peer medians: ROE -31.0% · P/E 25.0x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.